Despite the warning label, individuals continue to use them and the individual does not know what they are getting all the time. There is some research on the following peptide injections: Body Protection Compound-157 (BPC-157) Initial and pre-clinical-trial research suggest BPC-157 may promote musculoskeletal healing, which could explain its popularity among athletes (although it is banned in professional sports)
Other Related Information Mapping in Human Pancreatic Cancer Tissue by GLP-1 (7-36)-amide Antibody (H-028-11) Protocol for antibody staining Tissue Sample Human pancreas cancer tissues Fixative 10% formalin Embedding Paraffin Negative Control No primary antibody Pretreatment N/A Blocking 3% H2O2, 2% Normal Goat Serum Primary Antibody Rabbit Anti-GLP-1 (7-36)-NH2 Antiserum (Catalog No.: H-028-11) Optimal Dilution 1: 500 Secondary Antibody Goat Anti-Rabbit IgG, Biotinylated (1:400), 30 min Amplification Streptavidin-HRP (Vector), 1:400, 30 min Detection System HRP Substrate DAB (Sigma), 3 min Counterstained Hematoxylin, 30 sec Mapping in Rat Pancreas and Intestines by GLP-1 (7-37) Antibody (H-028-13) Rat Pancreatic and intestinal tissue Pre-immuno serum Intact 2% Normal Goat Serum Rabbit Anti-GLP-1 (7-37) (Human, Rat, Mouse, Porcine) Serum (Catalog No.:H-028-13) 1:500, 1 hour at RT ABC (Vector) (1:400, 30 min) with methyl green Rat pancreatic and intestinal sections with an antiserum for human GLP-1 (737) (Phoenix Pharmaceuticals, Mountain View, California, USA) at a concentration of 1/500
water-soluble protein a water-soluble protein injectable into body fluids without showing any substantial pharmacological activity at the concentration used in one unit dosage form of the present invention water-soluble protein a water-soluble protein injectable into body fluids without showing any substantial pharmacological activity at the concentration used in one unit dosage form of the present invention water-soluble protein a water-soluble protein injectable into body fluids without showing any substantial pharmacological activity at the concentration used in one unit dosage form of the present invention serum-soluble protein serum albumin, globulin, collagen and/or gelatin are preferred
Plant Cell 5 , 923 (1993)
